Trial Design Articles

How to Minimize Subjectivity in Dermatology Data

Dec 18, 2017

By Darcee Duke Strube

Until more sophisticated measures are created, a combination of investigator training and new imaging methods is the best way to create accurate, reproducible data across sites.

Three Steps to A Successful Combination Product Trial

Nov 28, 2017

By Cynthia Pritchard, PhD

Sponsors can streamline the design and execution of their clinical trials by following this three-step approach.

The Impact of Faster Drug Approvals on Oncology Clinical Trial Design

Sep 13, 2017

By Andrew Zupnick, PhD

Due to a shifting landscape because of faster drug approvals, this article offers strategies for sponsors to design clinical trials.

Exploring the Future of Clinical Research for Immune-Mediated Inflammatory Diseases

Mar 27, 2017

By Ian Braithwaite, Eteri Tsetskhladze, MD, PhD

In the search for more effective treatments and cures, there are challenges that sponsors and CROs must confront when conducting IMID clinical trials.

Developing New Clinical Endpoints for Immuno-Oncology Studies

Feb 23, 2017

By Chris Smyth, PhD

Drug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.

native1_300x100
lorem ipsum